Results 241 to 250 of about 1,263,421 (318)
Pediatric Developmental Safety Assessment: Are We Ready for the Next Thalidomide?
Pediatric drug development has achieved remarkable success in the last 20 years with over 1,000 products studied in pediatric patients. This success has been driven in part by an increased understanding of pediatric disease processes. The aspect that has been largely overlooked is the potential adverse effect of new drugs on pediatric developmental ...
Gilbert J. Burckart +6 more
wiley +1 more source
Experiences of participants in ETEC controlled human infection model studies. [PDF]
Wunderlich B +6 more
europepmc +1 more source
From the nationwide multicenter consortium, 8,163 patients undergoing drug‐eluting stent implantation were classified according to the presence of the CYP2C19 loss‐of‐function (LoF) allele: rapid or normal metabolizers (RMs/NMs) vs. intermediate or poor metabolizers (IMs/PMs), and clinical risk was stratified using the CHADS‐P2A2RC and TRS 2°P scores ...
Hyun Woong Park +22 more
wiley +1 more source
Herbal formulas and gastrointestinal motility: Bridging traditional medicine and mechanistic insights. [PDF]
Zalzman M, Banerjee A.
europepmc +1 more source
BIWT: a bioinformatics walkthrough for embedding spatial multiomics in agent-based models for virtual cells. [PDF]
Bergman DR +15 more
europepmc +1 more source
Lost in Translation: Harmonizing Terminology and Defining Mathematical Tools for Panel Optimization
ABSTRACT Spectral flow cytometry has evolved from a contentious idea into a mainstay of high‐parameter single‐cell analysis, yet its vocabulary (and the statistical reasoning behind it) remains a patchwork of overlapping, sometimes contradictory terms.
Bartek Rajwa, Mario Roederer
wiley +1 more source

